![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has enhanced its tamper-evident specialty label, Cap-Lock, with a special RFID inlay. Developed to help hospitals expand digitization initiatives, the label-and-cap security concept for prefilled syringes now also enables automated inventory and supply chain management, as well as digital first-opening indication. In doing so, the new Cap-Lock plus RFID solution offers efficient and reliable product authentication and enhanced patient safety.
Equipping syringes containing liquid medications with RFID-Labels poses a challenge, as both the container material and the composition of the liquid may impair reading of a UHF RFID-Label. Flag labels protruding from the container are frequently used for this purpose; however, these typically require additional space, are prone to being torn off and must be applied manually.
With Cap-Lock plus RFID, the RFID chip is integrated in the label. Cap-Lock is a combination of a cap adapter and label. The adapter is placed on top of the syringe’s primary closure and interlinked with it to equalize the diameter differences of the syringe body and closure. The label wraps around the syringe body and cap adapter and—once opened—provides irreversible tamper evidence due to an integrated perforation.
The RFID inlay is located in the upper part of the label at the level of the cap. Thus, it largely sits outside the liquid-filled area and enables reliable long-range reading. Due to the RFID functionality, digital first-opening evidence is now possible in addition to the previous, purely visual first-opening indication provided by the destroyed label. The RFID-Label can be automatically processed as part of the primary container’s normal labeling workflow.
For live monitoring and control of the logistic flow of materials and products in automated inventory and supply chain management, the data of syringes equipped with RFID-Labels can be automatically captured at various stations. As a result of reading the picked and placed products, current inventory information is consistently stored in a database. Additionally, integrity, first-opening or tampering with containers can be digitally monitored by means of the purpose-developed RFID-Sensor-Label.
In medication management, data stored on the RFID-Labels—such as product name, manufacturer, batch number and expiration date—is read automatically either individually or in bulk using simple handheld or specialty readers, and matched with a database. This enables exact tracking of inventories and provides transparency regarding medicines that are missing or approaching their expiration date. This helps protect patients against potential medication errors.
About Schreiner MediPharm
Based in the Munich area of Germany, Schreiner MediPharm is a global leader in the development and manufacture of innovative specialty labels with value-added benefits that have set the standard in the healthcare and pharmaceutical industries. Schreiner MediPharm’s expertise is based on over 65 years of experience. The family-owned company provides specialty labels and label printing services to the biggest names in the healthcare market around the world.
